In the G3a CKD stage APOE level was higher in the E2 subgroup (p < 0.001), whereas in the G4 CKD stage it was increased in the E3 subgroup (p < 0.05) compared to other subgroups (Fig. 3). This evidence concerns the gene APOE and chronic kidney disease.